NTI
Click for more information
6.58% 7.1¢ neurotech international limited

Ann: Phase II/III autism trial shows further benefits, page-15

  1. htae39
    1,629 Posts.
    lightbulb Created with Sketch. 148
    clock Created with Sketch.
    23/07/24
    11:27
    Post #: 74870882
    It doesn't. A successful NDA (new drug application) is what is required.

    Edit: Excludes off label, extended clinical use. OD is just to incentivise companies to target rare diseases. Autism does not quality, but Rett Syndrome does for example.
    Last edited by htae39: Tuesday, 11:28
    NTI Price at posting: 7.7¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.1¢ 		Change
-0.005(6.58%) 		Mkt cap ! $72.23M
Open High Low Value Volume
7.6¢ 7.8¢ 6.9¢ $135.0K 1.833M

Buyers (Bids)

No. Vol. Price($)
2 27000 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 33439 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.